Plan B OTC Submission Deemed "Not Approvable"
This article was originally published in The Pink Sheet Daily
Executive Summary
Barr will have to detail a mechanism for drugstores to screen women less than 16 years of age for nonprescription use of the emergency contraceptive. FDA's decision goes against the recommendation of its advisory panels.
You may also be interested in...
Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock
Response to "not approvable" letter for OTC availability of the emergency contraceptive includes information supporting Rx-only status for women 15 years of age and under and OTC status for women 16 and older.
Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock
Response to "not approvable" letter for OTC availability of the emergency contraceptive includes information supporting Rx-only status for women 15 years of age and under and OTC status for women 16 and older.
Bad Precedent? Plan B Rx/OTC Labeling May Have Implications For Existing OTCs – NEJM
Nonprescription drugs, such as aspirin and ibuprofen, could be reevaluated if Barr chooses simultaneous Rx/OTC marketing of levonorgestrel at the same dose for both populations.